Pittenger Christopher, Kelmendi Ben, Bloch Michael, Krystal John H, Coric Vladimir
Psychiatry (Edgmont). 2005 Nov;2(11):34-43.
Obsessive compulsive disorder (OCD) was once thought to be extremely rare, but recent epidemiological studies have shown it to be the fourth most common psychiatric disorder (after substance abuse, specific phobias, and major depression). OCD is often a chronic disorder that produces significant morbidity when not properly diagnosed and treated. The mainstay of treatment includes cognitive behavioral therapy and medication management. The use of clomipramine in the 1960s and then the introduction of serotonin reuptake inhibitors in the 1980s represented important advances in the pharmacologic treatment of OCD. Despite effective treatment modalities, many patients demonstrate only a partial response or are resistant to available medications. SRI-resistant OCD is one of the few diagnoses in modern psychiatry for which invasive neurosurgical procedures remain part of the established treatment armamentarium. We review current treatment strategies used in the management of OCD symptoms.
强迫症(OCD)曾被认为极为罕见,但最近的流行病学研究表明,它是第四大常见精神障碍(仅次于药物滥用、特定恐惧症和重度抑郁症)。强迫症通常是一种慢性疾病,若未得到正确诊断和治疗,会导致严重的发病情况。治疗的主要方法包括认知行为疗法和药物管理。20世纪60年代氯米帕明的使用以及随后80年代血清素再摄取抑制剂的引入,代表了强迫症药物治疗的重要进展。尽管有有效的治疗方式,但许多患者仅表现出部分反应或对现有药物有抗药性。对血清素再摄取抑制剂有抗药性的强迫症是现代精神病学中少数几种诊断之一,对于这些诊断,侵入性神经外科手术仍是既定治疗手段的一部分。我们回顾了目前用于管理强迫症症状的治疗策略。